Brp Group, Inc. BRP
We take great care to ensure that the data presented and summarized in this overview for BRP Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding BRP
View all-
Vanguard Group Inc Valley Forge, PA6.41MShares$257 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.75MShares$190 Million0.0% of portfolio
-
Bamco Inc New York, NY3.01MShares$120 Million0.33% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.71MShares$108 Million0.28% of portfolio
-
Macquarie Group LTD Australia, C32.58MShares$103 Million0.11% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.56MShares$103 Million0.65% of portfolio
-
Capital International Investors Los Angeles, CA2.34MShares$93.9 Million0.02% of portfolio
-
State Street Corp Boston, MA1.96MShares$78.3 Million0.0% of portfolio
-
Westwood Holdings Group Inc Dallas, TX1.69MShares$67.6 Million0.54% of portfolio
-
Geode Capital Management, LLC Boston, MA1.55MShares$62.1 Million0.01% of portfolio
Latest Institutional Activity in BRP
Top Purchases
Top Sells
About BRP
BRP Group, Inc. markets and sells insurance products and services in the United States. The company operates through four segments: Middle Market, Specialty, MainStreet, and Medicare. The Middle Market segment provides commercial risk management, employee benefits solutions, and private risk management for mid-to-large size businesses and high net worth individuals, as well as its families. The Specialty segment delivers specialty insurers, professionals, individuals, and industry businesses the access to specialty markets, as well as capabilities and programs requiring underwriting and placement. This segment also operates as a managing general agent of the Future platform, which delivers proprietary, technology-enabled insurance solutions. The MainStreet segment offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in its communities. The Medicare segment provides consultation for government assistance programs and solutions, including Medicare and Medicare Advantage to seniors and Medicare-eligible individuals through a network of primarily independent contractor agents. The company was founded in 2011 and is headquartered in Tampa, Florida.
Insider Transactions at BRP
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 04
2024
|
Laura Sherman |
BUY
Bona fide gift
|
Indirect |
3,036
+0.14%
|
-
|
Oct 04
2024
|
Laura Sherman |
SELL
Bona fide gift
|
Direct |
3,036
-100.0%
|
-
|
Oct 04
2024
|
Elizabeth Krystyn |
BUY
Bona fide gift
|
Indirect |
12,124
+0.65%
|
-
|
Oct 04
2024
|
Elizabeth Krystyn |
SELL
Bona fide gift
|
Direct |
12,124
-100.0%
|
-
|
Oct 03
2024
|
Laura Sherman |
SELL
Bona fide gift
|
Indirect |
60,992
-52.49%
|
-
|
Oct 03
2024
|
Laura Sherman |
BUY
Bona fide gift
|
Direct |
3,036
+50.0%
|
-
|
Oct 03
2024
|
Elizabeth Krystyn |
BUY
Bona fide gift
|
Indirect |
231,932
+32.75%
|
-
|
Oct 03
2024
|
Elizabeth Krystyn |
SELL
Bona fide gift
|
Indirect |
244,056
-52.48%
|
-
|
Oct 03
2024
|
Elizabeth Krystyn |
BUY
Bona fide gift
|
Direct |
12,124
+50.0%
|
-
|
Oct 01
2024
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+4.5%
|
-
|
Oct 01
2024
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+8.77%
|
-
|
Oct 01
2024
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+2.81%
|
-
|
Oct 01
2024
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+2.81%
|
-
|
Oct 01
2024
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+3.03%
|
-
|
Oct 01
2024
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+4.5%
|
-
|
Oct 01
2024
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+0.46%
|
-
|
Oct 01
2024
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
387
+4.5%
|
-
|
Oct 01
2024
|
Corbyn N. Galloway Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,747
-6.82%
|
$134,603
$49.1 P/Share
|
Aug 30
2024
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
50,000
-100.0%
|
$2,300,000
$46.74 P/Share
|
Aug 30
2024
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
50,000
+50.0%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 237K shares |
---|---|
Conversion of derivative security | 1.01M shares |
Other acquisition or disposition | 2.49M shares |
Bona fide gift | 344K shares |
Conversion of derivative security | 1.01M shares |
---|---|
Other acquisition or disposition | 5.03M shares |
Open market or private sale | 1.61M shares |
Bona fide gift | 413K shares |
Payment of exercise price or tax liability | 84.1K shares |